The national myelodysplastic syndromes (MDS) natural history study, data coordinating center (DCC), task order 03, september 1, 2016-february 28, 2018

Ended Awarded Last action

Contract number
HHSN26800003
Awardee
Awarding agency
Obligated
$13,756,583

Award facts

Opportunity
Contract value 100% obligated
$13,756,583.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 $0
Supplemental Agreement for work within scope P00009 $561,958
Other Administrative Action P00008 $0
Change Order P00007 $1,942,890
Change Order P00006 $0
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $2,425,208
Supplemental Agreement for work within scope P00003 $4,347,614
Supplemental Agreement for work within scope 2 $2,267,394
Supplemental Agreement for work within scope 1 $0
Original award $2,211,520
Show all 11

About this award

The National Heart, Lung, and Blood Institute awarded a delivery order contract to The Emmes Company, LLC for Task Order 03 supporting the National Myelodysplastic Syndromes Natural History Study Data Coordinating Center. The contract, awarded on August 30, 2016, with a ceiling value of $13.8 million, runs through February 28, 2018, with an ultimate completion date of December 31, 2025. Emmes will perform work at its facility in Potomac, Maryland. This is a cost-plus award fee delivery order with no set-aside designation, awarded competitively based on the contractor's demonstrated capabilities in clinical research coordination and data management.

The Emmes Company, LLC, a clinical research organization headquartered in Rockville, Maryland, specializes in providing data coordinating center services, biostatistical analysis, data management, and clinical trial coordination for federal agencies, particularly within the National Institutes of Health. Under this task order, Emmes will support the ongoing natural history study of myelodysplastic syndromes by managing data collection, analysis, and coordination activities. The contractor's selection reflects its extensive experience managing complex clinical research initiatives and multiple data coordinating center operations across various NIH institutes, positioning it to effectively support this important blood disorder research initiative.

Quick answers

Who was awarded contract HHSN26800003?

HHSN26800003 was awarded to The Emmes Company, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on August 30, 2016.

How much is contract HHSN26800003 worth?

The government has obligated $13,756,583 on HHSN26800003.

Is contract HHSN26800003 an order under another contract?

Yes. HHSN26800003 is a delivery order under HHSN268201400002I, an indefinite delivery contract.

Was contract HHSN26800003 competed?

The extent of competition for HHSN26800003 was full and open competition after exclusion of sources.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award